BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1399431)

  • 21. I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.
    Englaro EE; Gelfand MJ; Harris RE; Smith HS
    Radiology; 1992 Feb; 182(2):515-20. PubMed ID: 1732972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma.
    Ikekubo K; Habuchi Y; Jeong S; Yamaguchi H; Saiki Y; Ito H; Hino M; Higa T
    Clin Nucl Med; 1986 Nov; 11(11):777-80. PubMed ID: 3791787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
    Macdonald WB; Stevens MM; Dalla Pozza L; Bergin M; Menser MA; Howman-Giles R; Uren RF
    J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
    Müller-Gärtner HW; Erttmann R; Helmke K
    Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual Tc-99m MDP and I-123 MIBG images in focal pyelonephritis.
    Jacobs A; Lenoir P; Delree M; Ramet J; Piepsz A
    Clin Nucl Med; 1990 Nov; 15(11):821-4. PubMed ID: 2292157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesion detection in neuroblastoma with iodine-131-MIBG.
    Hattner RS; Parisi MT
    J Nucl Med; 1993 May; 34(5):865. PubMed ID: 8478727
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
    Giammarile F; Olier AL; Lumbroso J
    Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.
    Yeh SD; Larson SM; Burch L; Kushner BH; Laquaglia M; Finn R; Cheung NK
    J Nucl Med; 1991 May; 32(5):769-76. PubMed ID: 1902508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The place of mIBG imaging in the neuroblastoma diagnostic strategy.
    Giammarile F; Chauvot P
    Skeletal Radiol; 1997 May; 26(5):323. PubMed ID: 9194238
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
    Guerra P
    Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.
    Osmanagaoglu K; Lippens M; Benoit Y; Obrie E; Schelstraete K; Simons M
    Eur J Nucl Med; 1993 Dec; 20(12):1154-60. PubMed ID: 8299650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
    Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.
    Abrahamsen J; Lyck B; Helgestad J; Frederiksen PB
    Acta Oncol; 1995; 34(4):505-10. PubMed ID: 7605659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
    Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
    J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine].
    Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J
    Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
    Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
    Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
    Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
    J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.
    Jacobs A; Delree M; Desprechins B; Otten J; Ferster A; Jonckheer MH; Mertens J; Ham HR; Piepsz A
    Pediatr Radiol; 1990; 20(3):157-9. PubMed ID: 2352793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.